1
|
Gallier S, Topham A, Nightingale P, Garrick M, Woolhouse I, Berry MA, Pankhurst T, Sapey E, Ball S. Electronic prescribing systems as tools to improve patient care: a learning health systems approach to increase guideline concordant prescribing for venous thromboembolism prevention. BMC Med Inform Decis Mak 2022; 22:121. [PMID: 35505311 PMCID: PMC9066759 DOI: 10.1186/s12911-022-01865-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Accepted: 04/13/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Venous thromboembolism (VTE) causes significant mortality and morbidity in hospitalised patients. Risk factors for VTE are well known and there are validated risk assessment tools to support the use of prophylactic therapies. In England, reporting the percentage of patients with a completed VTE risk assessment is mandated, but this does not include whether that risk assessment resulted in appropriate prescribing. Full guideline compliance, defined as an assessment which led to an appropriate action-here prescribing prophylactic low molecular weight heparin where indicated, is rarely reported. Education, audit and feedback enhance guideline compliance but electronic prescribing systems (EPS) can mandate guideline-compliant actions. We hypothesised that a systems-based EPS intervention (prescribing rules which mandate approval or rejection of a proposed prescription of prophylactic low molecular weight heparin based on the mandated VTE assessment) would increase full VTE guideline compliance more than interventions which focused on targeting individual prescribers. METHODS All admitted patients within University Hospitals Birmingham NHS Foundation Trust were included for analysis between 2011 and 2020. The proportion of patients who received a fully compliant risk assessment and action was assessed over time. Interventions included teaching sessions and face-to-face feedback based on measured performance (an approach targeting individual prescribers) and mandatory risk assessment and prescribing rules into an EPS (a systems approach). RESULTS Data from all 235,005 admissions and all 5503 prescribers were included in the analysis. Risk assessments were completed in > 90-95% of all patients at all times, but full guideline compliance was lower (70% at the start of this study). Face-to-face feedback improved full VTE guideline compliance from 70 to 77% (p ≤ 0.001). Changes to the EPS to mandate assessment with prescribing rules increased full VTE compliance to 95% (p ≤ 0.001). Further amendments to the EPS system to reduce erroneous VTE assessments slightly reduced full compliance to 92% (p < 0.001), but this was then maintained including during changes to the low molecular weight heparin used for VTE prophylaxis. DISCUSSION An EPS-systems approach was more effective in improving sustained guideline-compliant VTE prevention over time. Non-compliance remained at 8-5% despite this mandated system. Further research is needed to assess the potential reasons for this.
Collapse
Affiliation(s)
- S. Gallier
- PIONEER Health Data Research Hub in Acute Care, Department of Health Informatics, Queen Elizabeth Hospitals NHS Foundation Trust, Mindlesohn Way, Edgbaston, Birmingham, B15 2WB UK
| | - A. Topham
- PIONEER Health Data Research Hub in Acute Care, Department of Health Informatics, Queen Elizabeth Hospitals NHS Foundation Trust, Mindlesohn Way, Edgbaston, Birmingham, B15 2WB UK
| | - P. Nightingale
- NIHR Clinical Research Facility, Queen Elizabeth Hospitals NHS Foundation Trust, Mindlesohn Way, Edgbaston, Birmingham, B15 2WB UK
| | - M. Garrick
- Department of Health Informatics, Queen Elizabeth Hospitals NHS Foundation Trust, Mindlesohn Way, Edgbaston, Birmingham, B15 2WB UK
| | - I. Woolhouse
- Respiratory Medicine, Queen Elizabeth Hospitals NHS Foundation Trust, Mindlesohn Way, Edgbaston, Birmingham, B15 2WB UK
| | - M. A. Berry
- Acute Medicine, Queen Elizabeth Hospitals NHS Foundation Trust, Mindlesohn Way, Edgbaston, Birmingham, B15 2WB UK
| | - T. Pankhurst
- Digital Healthcare and Department of Renal Medicine, Queen Elizabeth Hospitals NHS Foundation Trust, Mindlesohn Way, Edgbaston, Birmingham, B15 2WB UK
| | - E. Sapey
- grid.6572.60000 0004 1936 7486PIONEER Health Data Research Hub in Acute Care, University of Birmingham, Edgbaston, Birmingham, B15 2TH UK
| | - S. Ball
- HDR-UK Midlands Site and Better Care Programme, Queen Elizabeth Hospitals NHS Foundation Trust, Mindlesohn Way, Edgbaston, Birmingham, B15 2WB UK
| |
Collapse
|
2
|
Adizie J, Kadiri S, Ismail I, Woolhouse I, Turner A. A local qualitative study exploring facilitators and barriers to effective lung cancer decision making. Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30057-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
3
|
Perrotta F, Nankivell M, Adizie J, Elshafi M, Jafri S, Maqsood U, Munavvar M, Woolhouse I, Lerner A, Evison M, Booton R, Baldwin D, Janes S, Yarmus L, Bianco A, Navani N. Performance of endobronchial ultrasound-guided transbronchial needle aspiration in PD-L1 testing in patients with NSCLC. Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30095-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
4
|
West D, Beckett P, Khakwani A, Hubbard R, Dickinson R, Woolhouse I. S60 Lung cancer surgical survival and volume in england. Thorax 2016. [DOI: 10.1136/thoraxjnl-2016-209333.66] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
5
|
Beckett P, Khakwani A, Hubbard R, Vernon S, Jack R, Wood N, Plewa B, McAndrew N, Dickinson R, Navani N, Harden S, Woolhouse I. P104 Results of the first analysis of national lung cancer audit data based on cancer registration data. Thorax 2016. [DOI: 10.1136/thoraxjnl-2016-209333.247] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
6
|
Khakwani A, Hubbard R, Jack R, Wood N, Vernon S, Beckett P, Navani N, Harden S, Dickinson R, Woolhouse I. P103 Apples and pears? a comparison of two sources of lung cancer data in england. Thorax 2016. [DOI: 10.1136/thoraxjnl-2016-209333.246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
7
|
Hobbins S, Woolhouse I. 43 Quality standards for invasive tests for diagnosis and staging of lung carcinoma: a retrospective review at a tertiary referral hospital. Lung Cancer 2016. [DOI: 10.1016/s0169-5002(16)30060-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
8
|
Beckett P, Woolhouse I, Walters S, Benitez-Majano S, Muller P, West D, McPhail S, Broggio J, Peake MD. S72 Improving lung cancer survival in England evidenced through multiple data sources: Abstract S72 Table 1. Thorax 2015. [DOI: 10.1136/thoraxjnl-2015-207770.78] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
9
|
Callister MEJ, Baldwin DR, Akram AR, Barnard S, Cane P, Draffan J, Franks K, Gleeson F, Graham R, Malhotra P, Prokop M, Rodger K, Subesinghe M, Waller D, Woolhouse I. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 2015; 70 Suppl 2:ii1-ii54. [PMID: 26082159 DOI: 10.1136/thoraxjnl-2015-207168] [Citation(s) in RCA: 534] [Impact Index Per Article: 59.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- M E J Callister
- Department of Respiratory Medicine, Leeds Teaching Hospitals, Leeds, UK
| | - D R Baldwin
- Nottingham University Hospitals, Nottingham, UK
| | - A R Akram
- Royal Infirmary of Edinburgh, Edinburgh, UK
| | - S Barnard
- Department of Cardiothoracic Surgery, Freeman Hospital, Newcastle, UK
| | - P Cane
- Department of Histopathology, St Thomas' Hospital, London, UK
| | - J Draffan
- University Hospital of North Tees, Stockton on Tees, UK
| | - K Franks
- Clinical Oncology, St James's Institute of Oncology, Leeds, UK
| | - F Gleeson
- Department of Radiology, Oxford University Hospitals NHS Trust, Oxford, UK
| | | | - P Malhotra
- St Helens and Knowsley Teaching Hospitals NHS Trust, UK
| | - M Prokop
- Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands
| | - K Rodger
- Respiratory Medicine, St James's University Hospital, Leeds, UK
| | - M Subesinghe
- Department of Radiology, Churchill Hospital, Oxford, UK
| | - D Waller
- Department of Thoracic Surgery, Glenfield Hospital, Leicester, UK
| | - I Woolhouse
- Department of Respiratory Medicine, University Hospitals of Birmingham, Birmingham, UK
| | | | | |
Collapse
|
10
|
Cusworth K, O'Dowd E, Hubbard R, Beckett P, Peake MD, Woolhouse I. Variation in lung cancer resources and workload: results from the first national lung cancer organisational audit: Table 1. Thorax 2015; 70:1001-3. [DOI: 10.1136/thoraxjnl-2015-207166] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2015] [Accepted: 05/18/2015] [Indexed: 11/03/2022]
|
11
|
Beckett P, Edwards J, Fennell D, Hubbard R, Woolhouse I, Peake MD. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer 2015; 88:344-8. [PMID: 25863904 DOI: 10.1016/j.lungcan.2015.03.005] [Citation(s) in RCA: 78] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2014] [Revised: 01/24/2015] [Accepted: 03/03/2015] [Indexed: 11/29/2022]
Abstract
INTRODUCTION AND METHODS Malignant pleural mesothelioma (MPM) is an uncommon cancer with poor survival. We have used data collected for the UK National Lung Cancer Audit to assess current practice and to highlight regional variation in the management of mesothelioma patients, as well as to describe survival patterns in subgroups. RESULTS Our data on 8740 cases seen in hospitals in England and Wales is the largest cohort of MPM in the literature and represents approximately 80% of the total incident cases. 83% are male and median age is 73 years. Performance status is recorded in 81% and of these approximately 70% are PS 0-2. Stage is poorly recorded and unreliable in this dataset. The patient pathway is similar to lung cancer with approximately one-fifth having a non-elective referral to secondary care. A histo-cytological diagnosis is made in 87% and varies across organisations. Only 67% have anti-cancer treatment, and this also varies across organisations, but there has been an annual increase in the proportion receiving chemotherapy. Overall median survival was 9.5 months, with a 1YS of 41.4% and 3YS of 12.0%, but was strongly linked to performance status and histological subtype. Median survival also varied by cancer network from 209 days to 349 days, but appeared to increase from of 9.2 months in 2008 to 10.5 months in 2012. CONCLUSION Our data provide a large scale, detailed assessment of MPM epidemiology, treatment choices and outcomes. Incidence is increasing in line with predictions and uptake of treatments has generally mirrored publication of key MPM treatment trials, in particular increasing use of chemotherapy but low uptake of radical surgery. However, there is significant variation in care patterns and outcomes that may reflect limited expertise in area with low incidence. Initiatives to improve outcomes should include improved recording of clinical stage.
Collapse
Affiliation(s)
- P Beckett
- Department of Respiratory Medicine, Royal Derby Hospital, Derby, UK; Clinical Standards Department, Royal College of Physicians, London, UK.
| | - J Edwards
- Department of Cardiothoracic Surgery, Sheffield Teaching Hospitals NHS Trust, Northern General Hospital, Herries Road, Sheffield, UK
| | - D Fennell
- University of Leicester, Hodgkin Building, Lancaster Road, Leicester, UK
| | - R Hubbard
- Nottingham Respiratory Research Unit, Clinical Sciences Building, Nottingham City Hospital, NG5 1PB, UK
| | - I Woolhouse
- Clinical Standards Department, Royal College of Physicians, London, UK; Department of Respiratory Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK
| | - M D Peake
- Clinical Standards Department, Royal College of Physicians, London, UK; Department of Respiratory Medicine, Glenfield Hospital, Leicester, UK
| |
Collapse
|
12
|
Woolhouse I, Meace C, Greenaway K, Beckett P, Peake M. S70 Results From The First National Lung Cancer Organisational Audit. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.76] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
13
|
Beckett P, Yelland A, Woolhouse I, Peake M. S69 Rising Standards Of Care Continue In Year 9 Of The National Lung Cancer Audit. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.75] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
14
|
Beckett P, Woolhouse I, Yelland A, Peake M. 177 Chemotherapy treatment rates and survival are strongly related to speed of pathway in SCLC. Lung Cancer 2014. [DOI: 10.1016/s0169-5002(14)70178-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
15
|
Beckett P, Woolhouse I, Stanley R, Yelland A, Peake MD. S106 “Reasons to be cheerful”–data from year 8 of the national lung cancer audit: Abstract S106 Table 1. Thorax 2013. [DOI: 10.1136/thoraxjnl-2013-204457.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
16
|
Woolhouse I, Stanley R, Callister M, Barnard S, Page R, Beckett P, Peake M. S107 Treatment and outcomes for locally advanced (stage IIIA) lung cancer; 4 year experience from the National Lung Cancer Audit. Thorax 2013. [DOI: 10.1136/thoraxjnl-2013-204457.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
17
|
Beckett P, Woolhouse I, Stanley R, Fennell D, Edwards J, Hubbard R, Peake MD. P1 An analysis of 8,503 cases of mesothelioma from the National Lung Cancer Audit: Abstract P1 Table 1. Thorax 2013. [DOI: 10.1136/thoraxjnl-2013-204457.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
18
|
Beckett P, Hubbard R, Stanley R, Woolhouse I, Peake M. 207 Higher resection rates in non-small cell lung cancer are associated with better survival. Lung Cancer 2013. [DOI: 10.1016/s0169-5002(13)70207-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
19
|
|
20
|
Beckett P, Stanley R, Woolhouse I, Hubbard R, Tata L. S92 Risk Factors and Outcome For Emergency Presentation in Lung Cancer Patients: Abstract S92 Table 1. Thorax 2012. [DOI: 10.1136/thoraxjnl-2012-202678.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
21
|
Abstract
The National Lung Cancer Audit was developed to improve the quality and outcomes of services for patients with lung cancer, knowing that outcomes vary widely across the UK and are poor compared to other western countries. After five years the audit is capturing approximately 100% of the expected number of incident cases across hospitals in England, Wales, Scotland, Northern Ireland and Jersey. Measures of process and outcome have improved over the audit period, such as the histological confirmation rate (64-76%), the proportion of patients discussed in a multidisciplinary team meeting (78-94%), and the proportion of patients having anti-cancer treatment (43-59%), surgical resection (9-14%) and small cell lung cancer chemotherapy (58-66%). These national averages hide wide variations between hospitals providing lung cancer care which cannot be accounted for by differences in casemix. This paper describes the evolution of the audit, and describes the ways in which it may have improved clinical practice.
Collapse
Affiliation(s)
- P Beckett
- Burton Hospitals NHS Foundation Trust.
| | | | | | | |
Collapse
|
22
|
Jimenez S, Marting L, Draffan J, Woolhouse I. 133 Patient experience data collection in the improving lung cancer outcomes project: one year on. Lung Cancer 2012. [DOI: 10.1016/s0169-5002(12)70134-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
23
|
Hobbins S, Russell C, Phillips S, Walker C, Woolhouse I. 41 Lung cancer mimics and significant incidental findings in patients undergoing fast track pre-clinic computed tomography. Lung Cancer 2012. [DOI: 10.1016/s0169-5002(12)70042-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
24
|
Beckett P, Woolhouse I, Stanley R, Tata LJ, Peake MD, Darlinson L. S90 Nurse specialist input is independently associated with anti-cancer treatment in lung cancer. Thorax 2011. [DOI: 10.1136/thoraxjnl-2011-201054b.90] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
25
|
Jimenez S, Martin L, Aveling E, Martin G, Woolhouse I. P154 The improving lung cancer outcomes project: a study of the feasibility of a national reciprocal peer review and facilitated quality improvement programme. Thorax 2011. [DOI: 10.1136/thoraxjnl-2011-201054c.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
26
|
|
27
|
Lal A, Phillips S, Russell C, Woolhouse I. The novel use of fast track CT to select patients for lung cancer clinics: effect on clinic efficiency, waiting times, and patient satisfaction. Postgrad Med J 2011; 87:264-8. [DOI: 10.1136/pgmj.2010.109330] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
28
|
Christie S, Bell N, Malinowski T, Roberts A, Woolhouse I. P191 Development of a new patient reported experience measure for the improving lung cancer outcomes project. Thorax 2010. [DOI: 10.1136/thx.2010.151043.42] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
29
|
Woolhouse I, Stanley R, Beckett P, Peake MD. P211 Assessment of operability in early stage lung cancer: results from the national lung cancer audit. Thorax 2010. [DOI: 10.1136/thx.2010.151068.12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
30
|
Beckett P, Woolhouse I, Stanley R, Peake MD. P210 The national lung cancer audit--year 5 completeness and outcomes. Thorax 2010. [DOI: 10.1136/thx.2010.151068.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
31
|
|
32
|
Beckett P, Woolhouse I, Stanley R, Peake MD. The National Lung Cancer Audit in the United Kingdom: Results after 4 years. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.6123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
33
|
Beckett P, Woolhouse I, Stanley R, Peake M. The National Lung Cancer Audit Headline results in year 4. Lung Cancer 2010. [DOI: 10.1016/s0169-5002(10)70063-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
34
|
Beckett P, Stanley R, Woolhouse I, Yelland A, Peake M. Small cell lung cancer in the National Lung Cancer Audit. Lung Cancer 2010. [DOI: 10.1016/s0169-5002(10)70029-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
35
|
Woolhouse I, Beckett P, Stanley R, Peake M. Influence of case-mix adjustment on outcomes in the National Lung Cancer Audit. Lung Cancer 2010. [DOI: 10.1016/s0169-5002(10)70065-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
36
|
Lal A, Mahon B, Forde C, Woolhouse I. Achieving optimal performance of a new endobronchial ultrasound service: The effect of supervision and case selection. Lung Cancer 2010. [DOI: 10.1016/s0169-5002(10)70044-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
37
|
Woolhouse I, Mahon B. A comparison of a new endobronchial ultrasound service with an established endoscopic ultrasound service for mediastinal lymph node sampling. Lung Cancer 2009. [DOI: 10.1016/s0169-5002(09)70072-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
38
|
Woolley S, Nagra I, Meade S, Rajesh P, Ogunremi T, Woolhouse I. Positron emission tomography and nodal staging in non-small cell lung cancer? The Birmingham experience. Lung Cancer 2009. [DOI: 10.1016/s0169-5002(09)70060-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
39
|
Woolhouse I, Collinson H, Honeybourne D, Ferner RE. Pleural effusion and fever in a middle-aged Asian man. Postgrad Med J 1999; 75:687-8. [PMID: 10621886 PMCID: PMC1741406 DOI: 10.1136/pgmj.75.889.687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- I Woolhouse
- Department of Medicine, City Hospital, Birmingham, UK
| | | | | | | |
Collapse
|